More than 5 million women in the United States suffer from arm lymphedema after surgery and/or radiation for breast cancer, and the incidence and severity of lymphedema is worsened by doxorubicin (DOX) chemotherapy. The mechanism by which DOX contributes to lymphedema is poorly understood, but it is thought to involve multiple mechanisms of acute and delayed injury to the lymphatic system due to its cytotoxic effects. Alternatively, in this proposal, we will explore the hypothesis that DOX acutely and directly suppresses lymphatic contractile function and DOX-induced suppression of lymphatic flow can be reversed by pharmacological openers of voltage-gated L-type Ca2+ (CaL) channels. Using the rat mesenteric lymphatic system as our model, we will show for the first time that DOX at clinically relevant concentrations directly suppresses the spontaneous contractions (pumping) of lymph vessels, which propel extracellular fluid from peripheral tissues to the central veins to prevent lymphedema. The spontaneous contractions of lymph vessels rely on Ca2+ influx through CaL channels, and DOX-induced suppression of lymphatic contractions can be partly reversed by CaL channel openers. Based on these findings, we propose to i) define the direct effect of DOX on the contractile activity of isolated lymph vessels, ii) use patch-clamp techniques to determine if DOX blocks CaL channels in lymphatic smooth muscle cells, and iii) use in vivo flow cytometry with high-resolution intravital optical imaging to define the acute effet of DOX chemotherapy on in vivo lymphatic flow.

Public Health Relevance

Doxorubicin (DOX) chemotherapy is associated with an increased incidence and severity of arm lymphedema after breast cancer surgery or radiation therapy. Our new findings suggest that DOX may contribute to lymphedema by directly suppressing the spontaneous contractions ('pumping') of lymph vessels. Based on the hypothesis that DOX blocks calcium channels in the muscle cells of lymph vessels, we propose that calcium channel openers may provide a therapy to reverse DOX-induced suppression of lymphatic contractions. Thus, we propose to minimize the DOX-induced injury to the lymphatic system that is associated with lymphedema.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21CA187325-01A1
Application #
8879914
Study Section
Special Emphasis Panel (ZCA1-SRB-C (J1))
Program Officer
O'Mara, Ann M
Project Start
2015-03-09
Project End
2017-02-28
Budget Start
2015-03-09
Budget End
2016-02-29
Support Year
1
Fiscal Year
2015
Total Cost
$192,953
Indirect Cost
$62,453
Name
University of Arkansas for Medical Sciences
Department
Pharmacology
Type
Schools of Medicine
DUNS #
122452563
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Sarimollaoglu, Mustafa; Stolarz, Amanda J; Nedosekin, Dmitry A et al. (2018) High-speed microscopy for in vivo monitoring of lymph dynamics. J Biophotonics 11:e201700126